218 related articles for article (PubMed ID: 26535996)
1. Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition.
Katagiri D; Hamasaki Y; Doi K; Negishi K; Sugaya T; Nangaku M; Noiri E
Kidney Int; 2016 Feb; 89(2):374-85. PubMed ID: 26535996
[TBL] [Abstract][Full Text] [Related]
2. Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy.
Wong MY; Saad S; Wong MG; Stangenberg S; Jarolimek W; Schilter H; Zaky A; Gill A; Pollock C
PLoS One; 2020; 15(6):e0234617. PubMed ID: 32555665
[TBL] [Abstract][Full Text] [Related]
3. The inhibitor of semicarbazide-sensitive amine oxidase, PXS-4728A, ameliorates key features of chronic obstructive pulmonary disease in a mouse model.
Jarnicki AG; Schilter H; Liu G; Wheeldon K; Essilfie AT; Foot JS; Yow TT; Jarolimek W; Hansbro PM
Br J Pharmacol; 2016 Nov; 173(22):3161-3175. PubMed ID: 27495192
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
Wang SH; Yu TY; Tsai FC; Weston CJ; Lin MS; Hung CS; Kao HL; Li YI; Solé M; Unzeta M; Chen YL; Chuang LM; Li HY
Transl Res; 2018 Jul; 197():12-31. PubMed ID: 29653075
[TBL] [Abstract][Full Text] [Related]
5. Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model.
Wong M; Saad S; Zhang J; Gross S; Jarolimek W; Schilter H; Chen JA; Gill AJ; Pollock CA; Wong MG
Am J Physiol Renal Physiol; 2014 Oct; 307(8):F908-16. PubMed ID: 25143459
[TBL] [Abstract][Full Text] [Related]
6. Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration.
Schilter HC; Collison A; Russo RC; Foot JS; Yow TT; Vieira AT; Tavares LD; Mattes J; Teixeira MM; Jarolimek W
Respir Res; 2015 Mar; 16(1):42. PubMed ID: 25889951
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Semicarbazide-sensitive Amine Oxidase Reduces Atherosclerosis in Cholesterol-fed New Zealand White Rabbits.
Wang SH; Yu TY; Hung CS; Yang CY; Lin MS; Su CY; Chen YL; Kao HL; Chuang LM; Tsai FC; Li HY
Sci Rep; 2018 Jun; 8(1):9249. PubMed ID: 29915377
[TBL] [Abstract][Full Text] [Related]
9. Effects of repeated increasing doses of cisplatin as models of acute kidney injury and chronic kidney disease in rats.
Al Za'abi M; Al Salam S; Al Suleimani Y; Ashique M; Manoj P; Nemmar A; Ali BH
Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):249-259. PubMed ID: 32936352
[TBL] [Abstract][Full Text] [Related]
10. Blockade of cysteine-rich protein 61 attenuates renal inflammation and fibrosis after ischemic kidney injury.
Lai CF; Lin SL; Chiang WC; Chen YM; Wu VC; Young GH; Ko WJ; Kuo ML; Tsai TJ; Wu KD
Am J Physiol Renal Physiol; 2014 Sep; 307(5):F581-92. PubMed ID: 24920753
[TBL] [Abstract][Full Text] [Related]
11. Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury.
Negishi K; Noiri E; Maeda R; Portilla D; Sugaya T; Fujita T
Kidney Int; 2008 Jun; 73(12):1374-84. PubMed ID: 18368030
[TBL] [Abstract][Full Text] [Related]
12. Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury.
Peng X; Xu H; Zhou Y; Wang B; Yan Y; Zhang X; Wang M; Gao S; Zhu W; Xu W; Qian H
Exp Biol Med (Maywood); 2013 Aug; 238(8):960-70. PubMed ID: 23970411
[TBL] [Abstract][Full Text] [Related]
13. A role of liver fatty acid-binding protein in cisplatin-induced acute renal failure.
Negishi K; Noiri E; Sugaya T; Li S; Megyesi J; Nagothu K; Portilla D
Kidney Int; 2007 Aug; 72(3):348-58. PubMed ID: 17495861
[TBL] [Abstract][Full Text] [Related]
14. Mild elevation of urinary biomarkers in prerenal acute kidney injury.
Doi K; Katagiri D; Negishi K; Hasegawa S; Hamasaki Y; Fujita T; Matsubara T; Ishii T; Yahagi N; Sugaya T; Noiri E
Kidney Int; 2012 Nov; 82(10):1114-20. PubMed ID: 22854644
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of relaxin against cisplatin-induced nephrotoxicity in rats.
Yoshida T; Kumagai H; Kohsaka T; Ikegaya N
Nephron Exp Nephrol; 2014; 128(1-2):9-20. PubMed ID: 25403022
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of oleuropein attenuates cisplatin-induced acute renal injury in mice through inhibition of ERK signaling.
Potočnjak I; Škoda M; Pernjak-Pugel E; Peršić MP; Domitrović R
Mol Nutr Food Res; 2016 Mar; 60(3):530-41. PubMed ID: 26603374
[TBL] [Abstract][Full Text] [Related]
17. Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats.
Shalby AB; Assaf N; Ahmed HH
Toxicol Mech Methods; 2011 Sep; 21(7):538-46. PubMed ID: 21470069
[TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic peptide protects against cisplatin-induced acute kidney injury.
Nojiri T; Hosoda H; Kimura T; Miura K; Ishikane S; Tokudome T; Shintani Y; Inoue M; Miyazato M; Okumura M; Kangawa K
Cancer Chemother Pharmacol; 2015 Jan; 75(1):123-9. PubMed ID: 25385303
[TBL] [Abstract][Full Text] [Related]
19. Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.
Matsui K; Kamijo-Ikemorif A; Sugaya T; Yasuda T; Kimura K
Am J Pathol; 2011 Mar; 178(3):1021-32. PubMed ID: 21356355
[TBL] [Abstract][Full Text] [Related]
20. Human umbilical cord blood mononuclear cells protect against renal tubulointerstitial fibrosis in cisplatin-treated rats.
Li XW; Feng LX; Zhu XJ; Liu Q; Wang HS; Wu X; Yan P; Duan XJ; Xiao YQ; Cheng W; Peng JC; Zhao F; Deng YH; Duan SB
Biomed Pharmacother; 2020 Jan; 121():109662. PubMed ID: 31810124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
